Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | JAK2 | O60674 | 1/20 | 0.44 |
| ▸ | JAK1 | P23458 | 1/20 | 0.44 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8949097 | 1.00 | ALDH1A1 (0.50) | ALDH1A1MAPTHPGDNPSR1HSD17B10 | |
| SCHEMBL13240737 | 0.87 | ALDH1A1 (0.51) | ALDH1A1MAPTHPGDNPSR1HSD17B10 | |
| SCHEMBL1543215 | 0.87 | ALDH1A1 (0.51) | ALDH1A1MAPTHPGDNPSR1HSD17B10 | |
| Hydrochloric Acid SCHEMBL1543621 | 0.86 | ALDH1A1 (0.50) | ALDH1A1MAPTHPGDNPSR1HSD17B10 | |
| Hydrochloric Acid SCHEMBL1543620 | 0.86 | ALDH1A1 (0.50) | ALDH1A1MAPTHPGDNPSR1HSD17B10 | |
| SCHEMBL2370606 | 0.86 | ALDH1A1 (0.50) | ALDH1A1MAPTHPGDNPSR1HSD17B10 | |
| SCHEMBL29173102 | 0.85 | MEN1 (0.51) | ALDH1A1GRIN2BKMT2AMEN1SLC18A3 | |
| SCHEMBL1536103 | 0.83 | ALDH1A1 (0.47) | ALDH1A1MAPTHPGDNPSR1HSD17B10 | |
| SCHEMBL31630375 | 0.83 | ALDH1A1 (0.47) | ALDH1A1MAPTHPGDNPSR1HSD17B10 | |
| SCHEMBL1536115 | 0.83 | ALDH1A1 (0.47) | ALDH1A1MAPTHPGDNPSR1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230233557-A1 | FORMULATIONS COMPRISING HETEROCYCLIC PROTEIN KINASE INHIBITORS | SUMITOMO PHARMA ONCOLOGY, INC. (US) | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230233557-A1 | FORMULATIONS COMPRISING HETEROCYCLIC PROTEIN KINASE INHIBITORS | PIM1, GK, PIM2 | ALDH1A1 4536/4885MAPT 2290/4885HPGD 1564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.